Liu, C., Lou, W., Zhu, Y., Yang, J. C., Nadiminty, N., Gaikwad, N. W., . . . Gao, A. C. (2015). Intracrine androgens and AKR1C3 activation confer resistance to enzalutamide in prostate cancer. Cancer Res.
Παραπομπή Chicago StyleLiu, Chengfei, Wei Lou, Yezi Zhu, Joy C. Yang, Nagalakshmi Nadiminty, Nilesh W. Gaikwad, Christopher P. Evans, και Allen C. Gao. "Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer." Cancer Res 2015.
Παραπομπή MLALiu, Chengfei, et al. "Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer." Cancer Res 2015.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.